the potential of differentiation therapies for aml
Published 6 years ago • 660 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
3:20
differentiation syndrome with lower-intensity therapy for aml
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
3:40
how the aml treatment landscape has evolved with the use of novel combination therapies
-
2:34
the evolution of the aml treatment paradigm
-
1:17
combination therapy for the treatment of aml
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
7:03
jak2 v617f vaf as a diagnostic and prognostic marker for polycythemia vera and thrombosis risk
-
28:19
diagnosis: morphology, flow cytometry, cytogenetics, molecular testing, and risk-stratification
-
6:52
aml differentiation state & genotype influence anti-apoptotic protein expression & ven sensitivity
-
0:57
potential approval of quizartinib in aml & its place in the aml treatment regimen
-
2:09
advances in the management of fit adults with aml
-
1:09
menin inhibitors for the treatment of aml: insights into the covalent-101 trial
-
1:32
novel treatment combinations for flt3-mutated aml
-
1:21
trends in allosct for good-risk aml: a longitudinal study
-
2:58
evolution of the aml treatment paradigm
-
1:12
the value of flt3 inhibitors in aml and focus for future trial designs
-
3:18
the impact of secondary aml mutations on the prognosis of patients with npm1-mutated aml
-
1:12
understanding genetic and non-genetic mechanisms involve in aml disease progression
-
2:43
diagnostic tools for aml
-
1:30
combinations with flt3 inhibitors: the way forward for aml treatment
-
1:40
second-generation flt3 inhibitors in the treatment of flt3-itd aml
-
4:20
therapy-related all: etiology, prognosis, and treatment